Tissue-Selective Estrogen Complex Bazedoxifene and Conjugated Estrogens for the Treatment of Menopausal Vasomotor Symptoms

Author： Stovall Dale W.   Tanner-Kurtz Kirby   Pinkerton JoAnn V.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.71, Iss.13, 2011-09, pp. : 1649-1657

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bazedoxifene + conjugated estrogens in HT for the prevention of osteoporosis and treatment of vasomotor symptoms associated with the menopause

By Tella Sri Harsha   Gallagher John Christopher  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 17, 2013-12 ,pp. : 2407-2420

Informa Healthcare

Access to resources Recommend Favorite

Tissue-Selective Estrogen Complexes: A Promising Option for the Comprehensive Management of Menopausal Symptoms

By Archer David F.  

Drugs & Aging, Vol. 27, Iss. 7, 2010-07 ,pp. : 533-544

Adis International

Access to resources Recommend Favorite

MF101: a multi-component botanical selective estrogen receptor beta modulator for the treatment of menopausal vasomotor symptoms

By Leitman Dale C   Christians Uwe  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 7, 2012-07 ,pp. : 1031-1042

Informa Healthcare

Access to resources Recommend Favorite

Conjugated estrogens for the treatment of menopausal symptoms: a review of safety data

By Mirkin Sebastian   Komm Barry S   Pickar James H  

Expert Opinion on Drug Safety, Vol. 13, Iss. 1, 2014-01 ,pp. : 45-56

Informa Healthcare

Access to resources Recommend Favorite

Bazedoxifene and bazedoxifene combined with conjugated estrogens for the management of postmenopausal osteoporosis

By Lewiecki E Michael  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 10, 2007-10 ,pp. : 1663-1672

Informa Healthcare

Access to resources Recommend Favorite